Tami Tillotson Martin - 04 Aug 2022 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Sr. V.P., Regulatory Affairs
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
04 Aug 2022
Net transactions value
-$125,400
Form type
4
Filing time
05 Aug 2022, 16:31:13 UTC
Previous filing
25 Feb 2022
Next filing
23 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Options Exercise $39,500 +5,000 +5.7% $7.90 92,220 04 Aug 2022 Direct F1
transaction SUPN Common Stock Sale $164,900 -5,000 -5.4% $32.98 87,220 04 Aug 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Employee Stock Option (Right to Buy) Options Exercise $0 -5,000 -50% $0.000000 5,000 04 Aug 2022 Common Stock 5,000 $7.90 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted May 19, 2022.
F2 The option vested in four equal annual installments beginning on February 5, 2014.